Amerinet, Sandoz Sign Agreement for Pharmaceutical Products

Amerinet, a national healthcare group purchasing organization, has announced its private-label and sourcing company Amerinet Choice has signed an agreement with Sandoz, a division of the Novartis group, for Gemcitabine HCL and Levofloxacin/Dextrose pharmaceutical products.

Advertisement

 

The contract offers savings to Amerinet members on common 1 gram or 200 milligram powdered vials of Gemcitabine HCL and three different pre-mixed bags of Levofloxacin/Dextrose, according to an Amerinet news release.

 

The agreement is effective through Sept. 30, 2014.

 

Read the news release about the Sandoz agreement with Amerinet.

 

View all new Amerinet agreements.

 

More Articles Featuring Amerinet:

Amerinet Publishes Executive Briefing on Healthcare Reform and Accountable Care

Amerinet to Host Webinar Series on EMR and Meaningful Use Compliance

Patient Safety Tool: Amerinet Safe Handling of Hazardous Drugs Toolkit

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Uncategorized

Advertisement

Comments are closed.